We are getting closer and closer, to the start of Betonmace,
|
4
|
Resverlogix Corp.
|
Aug 04, 2015 08:31AM
|
Re: Add one to the list
|
4
|
Zenith Epigenetics
|
Sep 13, 2023 10:17AM
|
Re: zenith deal?
|
4
|
Zenith Epigenetics
|
Dec 15, 2018 11:41AM
|
Re: Top Shareholders of RVX
|
4
|
Resverlogix Corp.
|
Mar 01, 2020 10:54AM
|
Shenzhen Hepalink Halt.....
|
4
|
Zenith Epigenetics
|
Jun 26, 2017 12:54PM
|
Re: RVX tweet from Nov 7th
|
4
|
Resverlogix Corp.
|
Nov 12, 2016 06:01PM
|
Re: We need help!
|
4
|
Resverlogix Corp.
|
Feb 29, 2016 03:37PM
|
Re: My best guess on the orphan indication....
|
4
|
Resverlogix Corp.
|
Jul 15, 2015 07:30PM
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
4
|
Zenith Epigenetics
|
Sep 17, 2020 04:10PM
|
Re: Thoughts on AGM
|
4
|
Resverlogix Corp.
|
Nov 03, 2016 02:42PM
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
4
|
Resverlogix Corp.
|
Dec 10, 2019 10:33AM
|
Re: How is Zenith affected by the RVX top line miss
|
4
|
Zenith Epigenetics
|
Sep 30, 2019 07:15PM
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 10, 2022 07:19AM
|
Re: For sake of argument lets say ..
|
4
|
Zenith Epigenetics
|
Jun 01, 2022 06:58AM
|
Re: Clinicaltrials.gov
|
4
|
Zenith Epigenetics
|
May 13, 2018 03:15PM
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 09:50AM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
4
|
Zenith Epigenetics
|
Jan 30, 2019 07:36AM
|
Re: Thoughts on ZCC
|
4
|
Zenith Epigenetics
|
Sep 05, 2021 09:42AM
|
Re: Additional Exempt Distribution- 2023-03-31
|
4
|
Zenith Epigenetics
|
Apr 16, 2023 07:45PM
|
Re: The latest numbers for Alberta.
|
4
|
Resverlogix Corp.
|
Sep 17, 2021 11:26AM
|